Literature DB >> 189659

Receptors for peptide hormones. New insights into the pathophysiology of disease states in man.

C R Kahn, K Megyesi, R S Bar, R C Eastman, J S Flier.   

Abstract

The first step in the action of polypeptide hormones and many neurotransmitters is binding to receptor sites on the plasma membrane of the cell. These receptors are usually complex, high molecular weight proteins. Using a variety of receptor preparations and radioactively labeled hormones, radioreceptor assays for several hormones have been developed. These have allowed for assay of hormones for which no immunoassay exists. Such assays have shown increased levels of NSILA-s (an insulin-like peptide) in patients with nonpancreatic tumors and hypoglycemia. In disease states, the number or affinity of hormone receptors may be altered, leading to hormone resistant states such as the insulin resistance of obesity. A major factor regulating receptor concentration is the hormone itself. Several hormones seem to accelerate inactivation of their own receptors. Antibodies to membrane receptors are produced in at least three diseases and cause hormone resistance or mimic states of hormone excess.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 189659     DOI: 10.7326/0003-4819-86-2-205

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  20 in total

1.  Autoantibodies to the insulin receptor activate glycogen synthase in rat adipocytes.

Authors:  J C Lawrence; J Larner; C R Kahn; J Roth
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

2.  Change in glucose metabolism after long-term treatment with deflazacort and betamethasone.

Authors:  A Bruno; G Pagano; L Benzi; G Di Ciani; V Spallone; G Calabrese; A Passeri
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.

Authors:  C R Kahn; K Baird; J S Filier; D B Jarrett
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

4.  Endocrine function in a patient with asymmetrical acral hypertrophy and giantism: a possible variant of the Kippel-Trenaunay syndrome.

Authors:  R B Mims
Journal:  J Natl Med Assoc       Date:  1978-02       Impact factor: 1.798

5.  Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists.

Authors:  D Elias; M Rapoport; I R Cohen; Y Shechter
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

6.  Endocrine abnormalities in a patient with partial trisomy 4q.

Authors:  M A Angulo; M Castro-Magana; J Sherman; P J Collipp; J Milson; C Trunca; A N Derenoncourt
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

7.  Reduced insulin binding to hepatic plasma membranes in D-galactosamine-treated rats.

Authors:  W Bachmann; M Haslbeck; I Böttger; K D Hepp; H Mehnert
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

8.  Comparison of acute and subacute effects of deflazacort and prednisone on glucose metabolism in man.

Authors:  P Cavallo-Perin; A Bruno; A Ozzello; A M Dall'Omo; A Lombardi; M Cassader; B Imbimbo; G Pagano
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Human intraepithelial lymphocytes. Immunomodulation and receptor binding of vasoactive intestinal peptide.

Authors:  A I Roberts; A Panja; R E Brolin; E C Ebert
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

10.  IgE receptors on human basophils. Relationship to serum IgE concentration.

Authors:  F J Malveaux; M C Conroy; N F Adkinson; L M Lichtenstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.